campath 1 Search Results


human campath-1 antigen  (Shanghai Korain Biotech Co Ltd)
99
Shanghai Korain Biotech Co Ltd human campath-1 antigen
Human Campath 1 Antigen, supplied by Shanghai Korain Biotech Co Ltd, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/campath+1/Human+Campath-1+Antigen/custom%40e6590hu%4010%2E3390%2Fc9030079
Average 99 stars, based on 1 article reviews
human campath-1 antigen - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier
human campath-1 antigen, cd52 genlisa elisa  (Krishgen Biosystems)
N/A
ELISA for estimation of Human CAMPATH-1 Antigen, CD52 in serum, plasma and other biological fluids
   Buy from Supplier
anti cd52 polyclonal antibody  (Proteintech)
94
Proteintech anti cd52 polyclonal antibody
Primers used for RT-qPCR amplification.
Anti Cd52 Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/campath+1/CD52+Antibody/pmc09718428-92-36-39
Average 94 stars, based on 1 article reviews
anti cd52 polyclonal antibody - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
cd52 elisa kit  (Cusabio)
90
Cusabio cd52 elisa kit
Levels of sCD52 quantified by <t>ELISA.</t> (A) healthy blood donors (n = 45) and patients with CLL (n = 86). (B) patients with early CLL (n = 44) and with progressive CLL (progressive CLL, n = 42). (C) patients with early CLL and progressive CLL by Binet stage grading A (n = 39 and n = 6, early CLL and progressive CLL, respectively), vs. B/C (n = 4 and n = 36, early CLL and progressive CLL, respectively). (D) Levels of sCD52 and β2-microglobulin (β2m) in patients with early CLL (n = 26) and progressive CLL (n = 30). Statistical analyses were performed as unpaired Student’s t tests and linear regression analysis, data were logarithmically transformed.
Cd52 Elisa Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/campath+1/Human+CAMPATH-1+antigen(CD52)+ELISA+kit/pmc06441671-62-14-18
Average 90 stars, based on 1 article reviews
cd52 elisa kit - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
wild-type humanised campath-1 light chain  (Promega)
90
Promega wild-type humanised campath-1 light chain
Levels of sCD52 quantified by <t>ELISA.</t> (A) healthy blood donors (n = 45) and patients with CLL (n = 86). (B) patients with early CLL (n = 44) and with progressive CLL (progressive CLL, n = 42). (C) patients with early CLL and progressive CLL by Binet stage grading A (n = 39 and n = 6, early CLL and progressive CLL, respectively), vs. B/C (n = 4 and n = 36, early CLL and progressive CLL, respectively). (D) Levels of sCD52 and β2-microglobulin (β2m) in patients with early CLL (n = 26) and progressive CLL (n = 30). Statistical analyses were performed as unpaired Student’s t tests and linear regression analysis, data were logarithmically transformed.
Wild Type Humanised Campath 1 Light Chain, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/campath+1/wild+type+humanised+campath+1+light+chain/us07465790-120-1-13
Average 90 stars, based on 1 article reviews
wild-type humanised campath-1 light chain - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
alt campath 1- h  (Ilex Oncology Inc)
90
Ilex Oncology Inc alt campath 1- h
Levels of sCD52 quantified by <t>ELISA.</t> (A) healthy blood donors (n = 45) and patients with CLL (n = 86). (B) patients with early CLL (n = 44) and with progressive CLL (progressive CLL, n = 42). (C) patients with early CLL and progressive CLL by Binet stage grading A (n = 39 and n = 6, early CLL and progressive CLL, respectively), vs. B/C (n = 4 and n = 36, early CLL and progressive CLL, respectively). (D) Levels of sCD52 and β2-microglobulin (β2m) in patients with early CLL (n = 26) and progressive CLL (n = 30). Statistical analyses were performed as unpaired Student’s t tests and linear regression analysis, data were logarithmically transformed.
Alt Campath 1 H, supplied by Ilex Oncology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/campath+1/alt+campath+1++h/pm15621786-49-4-10
Average 90 stars, based on 1 article reviews
alt campath 1- h - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
campath 1  (Berlex Laboratories Inc)
90
Berlex Laboratories Inc campath 1
Levels of sCD52 quantified by <t>ELISA.</t> (A) healthy blood donors (n = 45) and patients with CLL (n = 86). (B) patients with early CLL (n = 44) and with progressive CLL (progressive CLL, n = 42). (C) patients with early CLL and progressive CLL by Binet stage grading A (n = 39 and n = 6, early CLL and progressive CLL, respectively), vs. B/C (n = 4 and n = 36, early CLL and progressive CLL, respectively). (D) Levels of sCD52 and β2-microglobulin (β2m) in patients with early CLL (n = 26) and progressive CLL (n = 30). Statistical analyses were performed as unpaired Student’s t tests and linear regression analysis, data were logarithmically transformed.
Campath 1, supplied by Berlex Laboratories Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/campath+1/campath+1/10__1097_slash_01__tp__0000062569__40977__66-168-17-23
Average 90 stars, based on 1 article reviews
campath 1 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
campath-1 therapy  (Adis International Limited)
90
Adis International Limited campath-1 therapy
Levels of sCD52 quantified by <t>ELISA.</t> (A) healthy blood donors (n = 45) and patients with CLL (n = 86). (B) patients with early CLL (n = 44) and with progressive CLL (progressive CLL, n = 42). (C) patients with early CLL and progressive CLL by Binet stage grading A (n = 39 and n = 6, early CLL and progressive CLL, respectively), vs. B/C (n = 4 and n = 36, early CLL and progressive CLL, respectively). (D) Levels of sCD52 and β2-microglobulin (β2m) in patients with early CLL (n = 26) and progressive CLL (n = 30). Statistical analyses were performed as unpaired Student’s t tests and linear regression analysis, data were logarithmically transformed.
Campath 1 Therapy, supplied by Adis International Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/campath+1/campath+1+therapy/pm18031177-128-21-25
Average 90 stars, based on 1 article reviews
campath-1 therapy - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
mouse campath-1 antigen  (Shanghai Korain Biotech Co Ltd)
90
Shanghai Korain Biotech Co Ltd mouse campath-1 antigen
Levels of sCD52 quantified by <t>ELISA.</t> (A) healthy blood donors (n = 45) and patients with CLL (n = 86). (B) patients with early CLL (n = 44) and with progressive CLL (progressive CLL, n = 42). (C) patients with early CLL and progressive CLL by Binet stage grading A (n = 39 and n = 6, early CLL and progressive CLL, respectively), vs. B/C (n = 4 and n = 36, early CLL and progressive CLL, respectively). (D) Levels of sCD52 and β2-microglobulin (β2m) in patients with early CLL (n = 26) and progressive CLL (n = 30). Statistical analyses were performed as unpaired Student’s t tests and linear regression analysis, data were logarithmically transformed.
Mouse Campath 1 Antigen, supplied by Shanghai Korain Biotech Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/campath+1/Mouse+Campath-1+Antigen/custom%40e1899mo%4010%2E21608%2Fejchem%2E2022%2E153001%2E6628
Average 90 stars, based on 1 article reviews
mouse campath-1 antigen - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
anti-campath-1 antigen cd52 antibody  (Boster Bio)
N/A
Boster Bio Anti-CAMPATH-1 antigen CD52 Antibody catalog # A03484. Tested in WB applications. This antibody reacts with Human,Mouse,Rat.
   Buy from Supplier
recombinant human campath-1 antigen(cd52),partial  (Cusabio)
N/A
   Buy from Supplier
mouse campath-1 antigen, cd52 genlisa elisa  (Krishgen Biosystems)
N/A
Enzyme Immunoassay for the Quantitative Determination of Mouse CAMPATH-1 antigen, CD52 in serum, plasma, tissues and other biological samples
   Buy from Supplier

Image Search Results


Primers used for RT-qPCR amplification.

Journal: Frontiers in Genetics

Article Title: Identification of susceptibility modules and hub genes of osteoarthritis by WGCNA analysis

doi: 10.3389/fgene.2022.1036156

Figure Lengend Snippet: Primers used for RT-qPCR amplification.

Article Snippet: CD4, SELL, ITGB2, and CD52 were detected using the rabbit anti-CD4 polyclonal antibody (Servicebio, GB11064) at 1:1,000, anti- SELL polyclonal antibody (Affinity Bioscience, Cat#DF6509) at 1:200, anti- ITGB2 polyclonal antibody (Affinity Bioscience, Cat#DF6896) at 1:200, and anti-CD52 polyclonal antibody (Proteintech, Cat No.21809-1-AP) at 1:200.

Techniques: Amplification

Expression of CD4, SELL, ITGB2, and CD52 proteins in clinical specimens of synovial tissues from TKA patients and patients undergoing knee arthroscopic surgery. (A) CD4, (B) SELL, (C) ITGB2, and (D) CD52.

Journal: Frontiers in Genetics

Article Title: Identification of susceptibility modules and hub genes of osteoarthritis by WGCNA analysis

doi: 10.3389/fgene.2022.1036156

Figure Lengend Snippet: Expression of CD4, SELL, ITGB2, and CD52 proteins in clinical specimens of synovial tissues from TKA patients and patients undergoing knee arthroscopic surgery. (A) CD4, (B) SELL, (C) ITGB2, and (D) CD52.

Article Snippet: CD4, SELL, ITGB2, and CD52 were detected using the rabbit anti-CD4 polyclonal antibody (Servicebio, GB11064) at 1:1,000, anti- SELL polyclonal antibody (Affinity Bioscience, Cat#DF6509) at 1:200, anti- ITGB2 polyclonal antibody (Affinity Bioscience, Cat#DF6896) at 1:200, and anti-CD52 polyclonal antibody (Proteintech, Cat No.21809-1-AP) at 1:200.

Techniques: Expressing

Levels of sCD52 quantified by ELISA. (A) healthy blood donors (n = 45) and patients with CLL (n = 86). (B) patients with early CLL (n = 44) and with progressive CLL (progressive CLL, n = 42). (C) patients with early CLL and progressive CLL by Binet stage grading A (n = 39 and n = 6, early CLL and progressive CLL, respectively), vs. B/C (n = 4 and n = 36, early CLL and progressive CLL, respectively). (D) Levels of sCD52 and β2-microglobulin (β2m) in patients with early CLL (n = 26) and progressive CLL (n = 30). Statistical analyses were performed as unpaired Student’s t tests and linear regression analysis, data were logarithmically transformed.

Journal: Leukemia & lymphoma

Article Title: Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia

doi: 10.1080/10428194.2017.1285027

Figure Lengend Snippet: Levels of sCD52 quantified by ELISA. (A) healthy blood donors (n = 45) and patients with CLL (n = 86). (B) patients with early CLL (n = 44) and with progressive CLL (progressive CLL, n = 42). (C) patients with early CLL and progressive CLL by Binet stage grading A (n = 39 and n = 6, early CLL and progressive CLL, respectively), vs. B/C (n = 4 and n = 36, early CLL and progressive CLL, respectively). (D) Levels of sCD52 and β2-microglobulin (β2m) in patients with early CLL (n = 26) and progressive CLL (n = 30). Statistical analyses were performed as unpaired Student’s t tests and linear regression analysis, data were logarithmically transformed.

Article Snippet: ELISA and other analyses sCD52 was quantified in plasma or serum by a commercial CD52 ELISA kit (CSB-EL004943HU, Cusabio Biotech, China) following the manufacturer’s instructions.

Techniques: Enzyme-linked Immunosorbent Assay, Transformation Assay

Levels of sCD52 and time to first treatment (TTFT) in ‘early’ CLL. (A) TTFT in patients with ‘early’ CLL divided by the median sCD52 level* (n = 44). (B) TTFT in patients with ‘early’ CLL at diagnosis based on sCD52 and IGHV mutational status, a sub-group of the patients shown in A (n = 34). Statistical analyses were performed as log rank test, cumulative incidence rates are shown. M-IGHV: mutated IGHV, UM-IGHV: unmutated IGHV. *The median level of sCD52 (274 ng/mL) in ‘early CLL’ patients with a sCD52 level above lower limit of quantification in the ELISA found to discriminate best between healthy donors and patients with CLL by ROC curve analysis, data not shown.

Journal: Leukemia & lymphoma

Article Title: Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia

doi: 10.1080/10428194.2017.1285027

Figure Lengend Snippet: Levels of sCD52 and time to first treatment (TTFT) in ‘early’ CLL. (A) TTFT in patients with ‘early’ CLL divided by the median sCD52 level* (n = 44). (B) TTFT in patients with ‘early’ CLL at diagnosis based on sCD52 and IGHV mutational status, a sub-group of the patients shown in A (n = 34). Statistical analyses were performed as log rank test, cumulative incidence rates are shown. M-IGHV: mutated IGHV, UM-IGHV: unmutated IGHV. *The median level of sCD52 (274 ng/mL) in ‘early CLL’ patients with a sCD52 level above lower limit of quantification in the ELISA found to discriminate best between healthy donors and patients with CLL by ROC curve analysis, data not shown.

Article Snippet: ELISA and other analyses sCD52 was quantified in plasma or serum by a commercial CD52 ELISA kit (CSB-EL004943HU, Cusabio Biotech, China) following the manufacturer’s instructions.

Techniques: Biomarker Discovery, Enzyme-linked Immunosorbent Assay